The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant.

Source:http://linkedlifedata.com/resource/pubmed/id/20385125

Eur. J. Pharmacol. 2010 Jun 25 636 1-3 88-95

Download in:

View as

General Info

PMID
20385125